Full of BS, as usual!
You know that no big pharma is going to partner with NWBO and therefore you do not want to place a bet that you know you will lose. I will give you until end of June 2025. The deal is big pharma PRs a partnership deal (it can be combo trial partnership or literally anything) and injects cash by end of June 2025. Cash injection can be any amount. Deal?
Stop with your BS that Flaskworks is needed for regulatory applications or running combo trials. Its not. LP herself said at the ASM that Flaskworks is not needed. She knows she will get sued if she lied along these lines. Thats why folks like you are deployed to toe that line on social media and shield the management for their non performance (to shareholders). They can apply to any regulatory agency with manual method and also run a combo trial with manual method just as they did with phase 3 GBM and the ph 1/2 trials at UCLA. No point wasting time.
I also gave you an opportunity to place a bet about your white knight scenario which you refused. Again, that bet is the white knight invests $50M or more at greater than $2B market cap valuation by end of March 2025. You say yes and I say no. Deal?
No big pharma is interested. No one will blink. However, LP is desperate as she has been selling cheapies at 30 cents. You can’t even back her leverage/negotiations skills at UK approval with the upcoming white knight raise.
Market Data 
Markets 
AI
